Tilray Inc. becomes the first cannabis producer to make an IPO in the United States.



[ad_1]

For Tilray Inc., one of the oldest and largest legal producers of medical cannabis in Canada, the road was long.

It began 18 months ago when the Nanaimo, BC, company listed and held meetings with potential investors on both sides of the border. Then, last summer, his plans changed after 15 US badet managers told Tilray that they would be much more forced to invest when they became public on a payday loan. important American stock market.

And that is what happened this week.

On Thursday, Tilray traded on the Nasdaq, becoming the first cannabis producer to complete an initial public offering in the United States. He sold nine million shares at US $ 17 each as part of his IPO, raising $ 153 million US and valuing the company at $ 1.6 billion US.

Stocks climbed more than 30 percent the day to close The strong demand from investors as part of the IPO allowed the company to sell its new shares beyond its previously wide range disclosed from US $ 14 to US $ 16. The offer – which, according to one source, was over 12 times oversubscribed – was sold to investors primarily in the United States. They included top-notch, blue-chip mutual funds that have not yet invested in the cannabis industry and whose mandates prevent them from owning shares listed outside of the US, said Brendan Kennedy, CEO of Tilray. as a company and for the sector as a whole, "he added." We think this means a shift in perceptions and a step towards further institutionalizing the sector. "

Tilray's marketing prior to his IPO signifies that he spent 100 hours in the air over the last month, traveling to meet potential investors in New York, Toronto, Edmonton, Denver, Boston, Baltimore, Chicago, San Francisco, London, Frankfurt, and Hong Kong.

In recent years, dozens of early-career marijuana companies with little history of exploitation have become public in Canada in recent years. It costs millions to build and operate a cannabis production plant, and it has not been easy for these companies to borrow money from banks or other sources. sell shares e n as a private entity.

The stock market was much more generous by an amazing winter rally in pot stocks. According to a Canaccord Genuity research report, public cannabis companies raised about $ 3.6 billion in the first six months of the year.

History Continues Under Advertising

[ad_2]
Source link